Loading page content…
Loading page content…
| Source: | Contracts Finder |
| Buyer: | CELL AND GENE THERAPY CATAPULT |
| Main Category: | Services |
| Procurement Method: | Open procedure (below threshold) |
| Tender Status: | Complete |
| Estimated Value (ex. VAT): | £140,000 |
| Release Date: | 5 November 2024 |
| Application Deadline: | 29 November 2024 |
| Procurement ID (OCID): | ocds-b5fd17-ff5396b8-6b82-4577-8962-b6f79780e913 |
| Notice Reference: | 7387281e-c1cb-48c0-a81c-28d1e36071df-799743 |
View Original Notice
Access the full notice on the official portal
Report Writing and Data Analysis Description: The ATTC programme is seeking for organisations and/or independent consultants to provide report writing and data analysis services in relation the outputs of milestones within the 7 workstreams of the Phase 2 Delivery plan. The overall aim is to manage the outputs of the work performed under the Programme in an effective and efficient way that promotes quality, unbiased interpretation of milestone results, and excellent communication that fully comprehends the methodologies that will be applied. The requirement for this service has been identified since funding from the NIHR, Innovate UK was provided, and CGT Catapult was tasked with coordinating the network. This requirement has been clearly identified within the delivery plan and approved by all the relevant bodies as key outputs of key milestones. These reports will not only demonstrate the impact of the work that is being carried out under the Phase 2 programme, but it enables for UK-wide distribution and familiarisation of key initiatives thereby pointing back to the overarching programme goal - Expand and embed the ATTC Network as a sustainable model within the NHS/NIHR to enable equitable and timely access to Advanced Therapies trials. The programme will be run across 4 years with the first report targeted for Mar 2025. There will be reports producible annually and reports produced as determined by the timelines of milestones.
Premarket Engagement for the Future Purchase of a Liquid Chromatography-Mass Spectrometer
CELL AND GENE THERAPY CATAPULT · WAC-154705
Premarket Engagement for the Future Purchase of a Fluorescence Activated Cell Sorter (FACS) Instrument and Associated Post Installation Services
CELL AND GENE THERAPY CATAPULT · WAC-183546
Premarket Engagement Specification for Custom column packing service (cGMP and non-cGMP grade)
CELL AND GENE THERAPY CATAPULT · WAC-183565
Pipeline status
Not addedContract imported automatically · AI writes the response
Application Deadline
29 November 2024
Closed
Estimated Value
£140,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →Apply online